Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Dice Therapeutics Inc (DICE)

Dice Therapeutics Inc (DICE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
BiondVax Pharmaceuticals (NASDAQ: BVXV) Positioned Favorably with Worldwide License to Anti-IL-17 NanoAbs Investor Brand Network - Tue Sep 5, 2023

BiondVax (NASDAQ: BVXV), a biotechnology company that recently signed an exclusive worldwide license to develop and commercialize innovative alpaca-derived nanosized antibodies (“NanoAbs”) targeting...

DICE : 47.55 (+0.06%)
LLY : 886.63 (+0.96%)
BVXV : 1.3600 (+3.82%)
Lilly Completes Acquisition of DICE Therapeutics PR Newswire - Wed Aug 9, 2023

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of DICE Therapeutics, Inc. (NASDAQ: DICE). The...

DICE : 47.55 (+0.06%)
LLY : 886.63 (+0.96%)
M&A Activity, Sales of Anti-IL-17 Drugs Suggest Upside Potential for BiondVax Pharmaceuticals (NASDAQ: BVXV) Investor Brand Network - Wed Jul 26, 2023

According to Goldman Sachs Research, the global pharmaceutical industry is sitting on about $700 billion in dealmaking firepower, expected to fuel M&A-driven growth as companies look to revamp their intellectual...

DICE : 47.55 (+0.06%)
LLY : 886.63 (+0.96%)
GS : 807.60 (+0.59%)
BVXV : 1.3600 (+3.82%)
Lilly Announces Extension of Tender Offer to Acquire DICE PR Newswire - Tue Jul 25, 2023

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the extension of the expiration of the tender offer to acquire all of the issued and...

DICE : 47.55 (+0.06%)
LLY : 886.63 (+0.96%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DICE, QUOT, TALS, CFMS PR Newswire - Tue Jul 11, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TALS : 2.72 (-0.73%)
CFMS : 2.26 (unch)
DICE : 47.55 (+0.06%)
QUOT : 3.99 (unch)
Moore Kuehn Encourages EMAN, NETI, PDCE, DICE, and NETI Investors to Contact Law Firm PR Newswire - Sun Jul 9, 2023

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

PDCE : 73.85 (-0.27%)
EMAN : 2.07 (+2.99%)
DICE : 47.55 (+0.06%)
NETI : 11.33 (+0.09%)
IMPORTANT ALERT: Halper Sadeh LLC Investigates DICE, IMNM, AJX PR Newswire - Mon Jul 3, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

IMNM : 19.30 (-1.58%)
DICE : 47.55 (+0.06%)
AJX : 3.02 (-0.66%)
Why Shares of Ventyx Biosciences Rose Monday Motley Fool - Mon Jul 3, 2023

The company has several promising autoimmune therapies.

VTYX : 14.00 (+0.14%)
DICE : 47.55 (+0.06%)
MRK : 118.10 (-1.28%)
LLY : 886.63 (+0.96%)
RXDX : 199.92 (+0.09%)
IMPORTANT ALERT: Halper Sadeh LLC Investigates TALS, DICE, NEX, NETI PR Newswire - Tue Jun 27, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NEX : 10.61 (+0.95%)
TALS : 2.72 (-0.73%)
DICE : 47.55 (+0.06%)
NETI : 11.33 (+0.09%)
Why Dice Therapeutics Stock Bolted Higher This Week Motley Fool - Thu Jun 22, 2023

The small-cap drugmaker fetched a hefty premium in a buyout deal with Eli Lilly.

DICE : 47.55 (+0.06%)
LLY : 886.63 (+0.96%)
PFE : 27.77 (+2.70%)

Barchart Exclusives

Meta Platforms Just Made Entergy a Top Stock to Buy... and It Pays a 2.49% Dividend Barchart - Mon Mar 30, 6:30PM CDT
Meta’s decision to fully fund seven new natural gas plants, 240 miles of 500 kV transmission, batteries, and up to 2.5 GW of solar to power its giant Louisiana AI data center effectively gives Entergy a multi‑decade growth runway with limited bill pressure on other customers, which is a rare setup for a regulated utility. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.